The DOI matches its Crossref record; 241 of the 254 references it cites were found in a registry or an index, and 1 are not checked yet; 1 of the 254 sources its claims cite were checked for support.
The Emerging Hallmarks of Cancer Metabolism
Open accessAbstract
Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and indirect consequence of oncogenic mutations. A common feature of cancer cell metabolism is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass. The alterations in intracellular and extracellular metabolites that can accompany cancer-associated metabolic reprogramming have profound effects on gene expression, cellular differentiation and the tumor microenvironment. In this Review, we have organized known cancer-associated metabolic changes into six hallmarks: (1) deregulated uptake of glucose and amino acids, (2) use of opportunistic modes of nutrient acquisition, (3) use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH production, (4) increased demand for nitrogen, (5) alterations in metabolite-driven gene regulation, and (6) metabolic interactions with the microenvironment. While few tumors display all six hallmarks, most display several. The specific hallmarks exhibited by an individual tumor may ultimately contribute to better tumor classification and aid in directing treatment.
Verified 2026-10-09 · 1 reference not checked yet
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review organizes known cancer-associated metabolic changes into six hallmarks: deregulated uptake of glucose and amino acids, opportunistic modes of nutrient acquisition, use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH production, increased demand for nitrogen, alterations in metabolite-driven gene regulation, and metabolic interactions with the microenvironment. The authors argue that while few tumors display all six hallmarks, most display several, and the specific hallmarks exhibited may aid tumor classification and treatment direction.
Key findings
- Cancer cells acquire nutrients through oncogene-driven constitutive uptake: PI3K/Akt signaling promotes GLUT1 expression and translocation and potentiates hexokinase and phosphofructokinase, while c-myc drives glutamine transporter (ASCT2, SN2) and glutaminase (GLS1) expression; Rb loss upregulates ASCT2 and GLS1 via E2F.
- Opportunistic nutrient acquisition allows survival under scarcity: Ras- or c-Src-driven macropinocytosis enables lysosomal degradation of extracellular protein (albumin at 20–30 mg/mL supports KRASG12D MEF proliferation without leucine), and mTORC1 inhibitors enhance this route — rapamycin suppresses proliferation at the tumor margin but enhances it in the poorly vascularized tumor core.
- Proliferating cells divert glycolytic intermediates into biosynthesis: cancer cells may use as much as 50% of glucose-derived carbon for serine biosynthesis, and stepwise oxidation of one-carbon-THF species can produce up to 50% of cellular NADPH; PKM2 (rather than PKM1) predominates in essentially all cancer cells and is inhibited by tyrosine phosphorylation and activated by serine.
- Metabolite-driven gene regulation links metabolism to epigenetics: mutant IDH1/IDH2 produce 2-HG that competitively inhibits α-ketoglutarate-dependent dioxygenases, and SDH/FH loss accumulates succinate/fumarate, all producing hypermethylation phenotypes; lactate accumulation promotes M2 macrophage polarization, angiogenesis, and immune-permissive microenvironments.
Methods
- Narrative review/Perspective synthesizing published literature on cancer metabolism; the authors state they organize known cancer-associated metabolic changes into six hallmarks.
- No primary data, sample, or statistical analysis is reported; evidence is drawn from cited studies across cell lines, mouse models, patient samples, and clinical imaging (e.g., 18F-FDG and 18F-glutamine PET).
- Not stated in the paper for any systematic search strategy, inclusion criteria, or quantitative synthesis.
Limitations
- The paper states that most studies to date have focused on glucose and glutamine metabolism, and that the contributions of other nutrients (sulfur-containing amino acids, essential fatty acids, choline, trace metals, vitamins, and microbiota-derived metabolites) are only beginning to be understood.
- The paper notes that cell lineage context and potential secondary effects of adaptation to tissue culture conditions may influence findings such as the choice of anaplerotic substrate (glutamine vs. glucose-derived pyruvate carboxylation).
- Evident from the text: as a narrative review without primary data or systematic methodology, the six-hallmark framework is an organizing proposal rather than an empirically validated classification, and the authors state that few tumors display all six hallmarks.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
162 Not checked yet · 73 No basis given · 48 Own interpretation · 1 Supported · 1 Sources not found
Every source the paper cites for this claim was checked and supports it.
In the paper
“expression of mutant Ras or c-Src alleles provides cells with a mechanism that allows them to recover free amino acids through the lysosomal degradation of extracellular proteins”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Supportedcites Commisso et al., 2013 source
The paper reports that degradation of extracellular albumin in oncogenic Ras-expressing cells depends on lysosomal hydrolases and yields intracellular amino acids. It also reports that cells expressing constitutively active Src internalize and degrade extracellular albumin, which can augment their amino acid supply. The indexed passages are labeled Abstract; no page number is provided. (LLM, conf=0.91)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and indirect consequence of oncogenic mutations.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
In the paper
“In such a manner, intracellular glutamine may facilitate the import of a broad range of LAT1 substrates, including leucine, isoleucine, valine, methionine, tyrosine, tryptophan and phenylalanine”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Yanagida et al., 2001 source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“when deprived of growth factors, hematopoietic and neuronal cells fail to consume glucose in quantities sufficient to even maintain cellular bioenergetics”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the optimal growth of cultured HeLa cells requires a 10- to a 100-fold molar excess of glutamine in culture medium relative to other amino acids”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Eagle, 1955 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Thus, glutamine provides the nitrogen required for the biosynthesis of purine and pyrimidine nucleotides, glucosamine-6-phosphate, as well as non-essential amino acids.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“glutamine was found to be the most rapidly consumed amino acid by Ehrlich ascites carcinomas as well as by a number of hepatomas and carcinosarcomas proliferating in vivo”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Marquez et al., 1989 source
- Not checked yetcites Sauer et al., 1982
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Glutamine, a second principal growth-supporting substrate contributes not only carbon, but also reduced nitrogen for the de novo biosynthesis of a number of diverse nitrogen-containing compounds.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“numerous tumorigenic contexts are associated with the depletion of glutamine from the tumor environment as compared to the corresponding normal tissue”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The alterations in intracellular and extracellular metabolites that can accompany cancer-associated metabolic reprogramming have profound effects on gene expression, cellular differentiation and the tumor microenvironment.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
- It may state two separate claims as one. 87
- Probably not a substantial claim. 15
In the paper
“This observation has been confirmed in a variety of tumor contexts and shown to correlate with poor tumor prognosis”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Som et al., 1980
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“tumorigenesis-associated metabolic alterations encompass all stages of cell-metabolite interaction, (a) affecting the metabolite influx through conferring an increased ability to acquire the necessary nutrients; (b) shaping the way the nutrients are preferentially assigned to metabolic pathways that contribute to cellular tumorigenic properties, as well as (c) exerting long-ranging effects on”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INTRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Normally, despite being surrounded by nutrient-rich plasma and the extracellular fluid, metazoan cells do not import nutrients in a constitutive manner. On the contrary, nutrient uptake is strictly regulated by growth factor signaling”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Thompson, 2011 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“controlled oxidation of carbon skeletons of glucose and glutamine allows a cell to capture their reducing power either in the form of NADH and FADH2, which mediate the transfer of electrons to the electron transport chain to fuel ATP generation, or in the form of a related cofactor NADPH, which provides reducing power for a wide variety of biosynthetic reactions, as well as helps maintain cellular”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Positron emission tomography (PET)-based imaging of the uptake of a radioactive fluorine-labeled glucose analog, 18F-fluorodeoxyglucose (18F-FDG) has been successfully used in the clinic for tumor diagnosis and staging, as well as for monitoring responsiveness to treatment”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Almuhaideb et al., 2011
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“This, in turn, negatively affects cell size, mitochondrial potential and ATP generation – all despite the abundance of glucose in the culture medium”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Rathmell et al., 2000
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In order to fulfill the biosynthetic demands associated with proliferation, a cell must increase the import of nutrients from the environment.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Two principal nutrients that support survival and biosynthesis in mammalian cells are glucose and glutamine.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“mTORC1 inhibitors greatly increase the cellular ability to recover amino acids from captured extracellular protein and enhance their growth in the absence of essential amino acids”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Not checked yetcites Palm et al., 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“free amino acids can be recovered from the engulfment and digestion of entire living cells via a process known as entosis (Figure 3B), as well as from phagocytosis of apoptotic cellular corpses”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Not checked yetcites Krajcovic et al., 2013 source
- Not checked yetcites Stolzing and Grune, 2004
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“c-myc induces the transcription of glutamine transporters ASCT2 and SN2, and in addition, promotes expression of glutamine-utilizing enzymes glutaminase (GLS1), phosphoribosyl pyrophosphate synthetase (PRPS2) and carbamoyl-phosphate synthetase 2 (CAD)”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Eberhardy and Farnham, 2001
- Not checked yetcites Gao et al., 2009 source
- Not checked yetcites Mannava et al., 2008
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“While rapamycin suppresses cancer cell proliferation at the tumor margin where the vascular delivery of nutrients is effective, rapamycin enhances cell proliferation within the poorly-vascularized tumor core by promoting enhanced lysosomal degradation of extracellular proteins”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Not checked yetcites Palm et al., 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“subsequent investigations into the mitochondrial status of tumor cells have shown that by and large, tumor cells possess functional mitochondria and retain the ability to conduct oxidative phosphorylation.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, KRAS-mutant cells may not only have a nutritional advantage over their non-mutant neighbors, but also actively eliminate the latter.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“exogenous expression of a constitutively active form of Akt alone can stimulate glycolysis and is sufficient to restore cell size, viability, mitochondrial potential and ATP levels in growth factor-deprived cells in a manner that is dependent upon the presence of glucose in the culture medium”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Plas et al., 2001
- Not checked yetcites Rathmell et al., 2003 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These observations suggest that, rather than being an adaptation to a defect in respiration, the Warburg effect is a regulated metabolic state and may, in fact, be beneficial during a time of increased biosynthetic demand.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Culturing mammary epithelial cells under conditions where the cells are detached from the extracellular matrix compromises glucose uptake and results in a depressed mitochondrial potential and decreased ATP levels”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Grassian et al., 2011
- Not checked yetcites Schafer et al., 2009 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Akt potentiates the activity of the hexokinase (HK), which phosphorylates glucose molecules, thus preventing their efflux back into the extracellular space, as well as of the phosphofructokinase (PFK) enzyme, which catalyzes the key irreversible step of glycolysis”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Deprez et al., 1997
- Not checked yetcites Gottlob et al., 2001
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Other oncogenic signaling proteins - notably, Ras, have been found to upregulate GLUT1 mRNA expression and increase cellular glucose consumption”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Murakami et al., 1992
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, the utilization of extracellular protein as nutrients is repressed by mTORC1 under amino acid-replete conditions and is only utilized as an emergency source in conditions when free amino acids are insufficient.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“generation of palmitic acid consumes 14 reducing equivalents, while building a cholesterol molecule requires 26”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Lunt and Vander Heiden, 2011 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the 18F-FDG-PET signal intensity in tumors correlates closely with the level of PI3K/Akt pathway activity, and is attenuated by PI-3 kinase and receptor tyrosine kinase inhibitors”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Benz et al., 2011
- Not checked yetcites Lheureux et al., 2013
- Not checked yetcites Ma et al., 2009
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In contrast to the effect of KRASG12D, PI3K/Akt signaling does not promote cellular utilization of extracellular protein, despite the ability of this pathway to stimulate the uptake of low molecular weight nutrients”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Not checked yetcites Palm et al., 2015
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“PI3K/Akt signaling promotes both the expression of glucose transporter GLUT1 mRNA and the translocation of GLUT1 protein from the endomembranes to the cell surface”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Barthel et al., 1999
- Not checked yetcites Wieman et al., 2007
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A designated donor of reducing equivalents that is used in cellular biosynthetic reactions is NADPH.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A first committed step of hexosamine biosynthesis is a glutamine fructose-6-phospate aminotransferase 1 (GFPT1)-catalyzed production of glucosamine-6-phosphate from fructose-6-phosphate and glutamine.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“A rate-limiting serine biosynthesis enzyme, 3-phosphoglycerate dehydrogenase (PHGDH), is frequently focally amplified in breast cancer and melanoma and is required for the growth of PHGDH-amplified cells in vitro as well as in vivo”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites LeBleu et al., 2014
- Not checked yetcites Viale et al., 2014 source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glycolytic intermediates leave glycolysis to take part in diverse biosynthetic reactions; accordingly, the rate-limiting enzymes within branching pathways of glycolysis are frequently upregulated in tumors.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“While the de novo biosynthesis of fatty acids is low in normal adult tissues – with the exception of lipogenic tissues such as liver, adipose tissue or mammary epithelium in the period of lactation, tumorigenesis is associated with a dramatic increase in lipid production (Li and Cheng, 2014; Menendez and Lupu, 2007).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Li and Cheng, 2014
- Not checked yetcites Menendez and Lupu, 2007
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“By using FAD as an electron acceptor, the mGPDH-catalyzed reaction reduces net mitochondrial electrical chemical potential from NADH generated via glycolysis.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, increased ROS levels facilitate the activation of HIF1α and NRF2 transcription factors, thus promoting transcriptional programs that further contribute to tumorigenesis (Bertout et al., 2008; Sporn and Liby, 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Bertout et al., 2008
- Not checked yetcites Sporn and Liby, 2012 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“First in the series of these branching pathways is the pentose phosphate pathway (PPP), in which glucose-6-phosphate becomes partially oxidized to generate NADPH and ribose-5-phosphate – a structural component of nucleotides.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By converting excess pyruvate to lactate, proliferating cells prevent accumulation of cytosolic NADH and reduce ATP production promoting continued cytosolic glucose metabolism free from feedback repression by excess mitochondrial ATP generation.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The key enzymes in the pathway, transketolase-like 1 (TKTL1) and transaldolase (TALDO) are frequently overexpressed in cancer”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Wang et al., 2011a
- Not checked yetcites Xu et al., 2009b
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“This step is regulated by pyruvate kinase (PK), an enzyme that converts phosphoenolpyruvate to the final product of glycolysis, pyruvate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Any excess glycolytic flux not utilized for biosynthesis is preferentially converted to lactate to help preserve a sufficient pool of NAD+ to sustain glycolysis and avoid flooding the mitochondria with a supply of NADH that would suppress the TCA cycle.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“To this end, ROS act as inhibitors of protein phosphatases such as PTEN and PTP1B, as well as activators of Src family kinases and MAPK (Denu and Tanner, 1998; Kamata et al., 2005; Lee et al., 2002; Yan and Berton, 1996).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Denu and Tanner, 1998
- Not checked yetcites Kamata et al., 2005 source
- Not checked yetcites Lee et al., 2002
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“DHAP is converted by glycerol-3-phosphate dehydrogenase 1 (GPD1) into glycerol-3-phosphate, which is utilized in the biosynthesis of diverse phospholipids, a major structural component of cellular membranes.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“wild-type, but not the mutant, p53 inhibits PPP by directly binding and inactivating the rate-limiting PPP enzyme glucose-6-phosphate dehydrogenase (G6PD)”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Jiang et al., 2011
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Thus, PKM2 is inhibited by tyrosine phosphorylation and activated by serine (Chaneton et al., 2012; Christofk et al., 2008b; Ye et al., 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Chaneton et al., 2012
- Not checked yetcites Christofk et al., 2008b
- Not checked yetcites Ye et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“While PKM1 is more efficient at producing pyruvate, the majority of proliferating cells and essentially all cancer cells express primarily the PKM2 variant”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Christofk et al., 2008a
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Though glycolysis is classically depicted as a single chain of molecular events that leads to the generation of pyruvate, a number of glycolytic intermediates can be diverted into branching pathways, generating diverse biosynthetic precursors.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Through the generation of N-acetylglucosamine (GlcNAc), a substrate for N- and O-linked glycosylation, the hexosamine pathway provides substrates for cellular glycosylation reactions as well as heparan sulfate and hyaluronic acid biosynthesis, potentiates receptor-mediated signaling and regulates the stability of select proteins, including c-myc”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Itkonen et al., 2013
- Not checked yetcites Spiro, 2002
- Not checked yetcites Wellen et al., 2010
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Among such populations are stem-like subclones that emerge following the oncogene ablation in vivo, as well as circulating tumor cells (CTCs) (LeBleu et al., 2014; Viale et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites LeBleu et al., 2014
- Not checked yetcites Viale et al., 2014 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In support of this paradigm, a reintroduction of the PKM1 isoform compromises cancer cell proliferation and tumorigenesis in vivo, in part by negatively affecting serine-dependent biosynthesis (Ye et al., 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Ye et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“while the acetyl-CoA serves as a precursor for lipid biosynthesis and protein acetylation.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, c-myc not only facilitates glutamine uptake, but also promotes its utilization in the biogenesis of purine and pyrimidine bases.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, activity of CAD enzyme is regulated via phosphorylation by MAPK and by mTORC1-dependent S6 kinase (Ben-Sahra et al., 2013; Graves et al., 2000; Robitaille et al., 2013).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A non-essential amino acid containing two atoms of reduced nitrogen, glutamine serves as the principal way in which reduced nitrogen is transported between cells in metazoan organisms.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Thus, one glutamine molecule is used in the production of uracil and thymine, cytosine and adenine each require two, and building a guanine base costs a cell three molecules of glutamine.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In addition to being utilized for nucleotide biosynthesis, glutamine can be directly deamidated to glutamate by glutaminase which is frequently upregulated in cancer cells in a c-myc-dependent manner.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“ASNS is frequently upregulated in tumors and is associated with poor prognosis (Sircar et al., 2012; Zhang et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
What the sources say
- Not checked yetcites Sircar et al., 2012
- Not checked yetcites Zhang et al., 2014 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Imported acetate is converted to acetyl-CoA in a reaction catalyzed by acetyl-CoA synthetase 2 (ACSS2), which is a target for amplification in breast cancer.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In fact, all three major components involved in fatty acyl chain biosynthesis – ACLY, ACC and FASN – are frequently upregulated in transformed cells; furthermore, their inhibition reduces tumor cell growth in vitro and in vivo (Chajes et al., 2006; Flavin et al., 2010; Migita et al., 2008; Milgraum et al., 1997).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These reports highlight that the cell lineage context, as well as potential secondary effects associated with the adaptation of cells to tissue culture conditions may play an important role in the choice of an anaplerotic substrate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In a process referred to as reductive carboxylation, a section of the TCA cycle reverses itself, converting α-ketoglutarate into citrate, which can be then used to generate a source of cytosolic acetyl-CoA (Metallo et al., 2012; Wise et al., 2011).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Glutamine can be captured in mitochondria by glutaminase and the resulting glutamate converted into α-ketoglutarate by either glutamate dehydrogenase or amino acid transaminases.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“An increased capacity for the producing lipids de novo not only facilitates the formation of lipid bilayers, but also enables a cell to alter its membrane composition in favor of oxidative damage-resistant saturated fatty acids as means of adapting to oxidative stress (Rysman et al., 2010).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Rysman et al., 2010
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A carrier of four nitrogen atoms, arginine serves as a precursor for a wide variety of nitrogenous compounds, among which are polyamines, creatine, agmatine and pyrroline-5-carboxylate, a precursor for the biosynthesis of proline.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Moreover, PC inhibition in NSCLC-derived cell lines suppresses fatty acid biosynthesis and dramatically reduces proliferation even in the presence of ample glutamine (Sellers et al., 2015).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Sellers et al., 2015
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, hypoxia-associated deficit of acetyl-CoA can be augmented not only through the reductive carboxylation of α-ketoglutarate, but also by increasing the utilization of free acetate from plasma and interstitial fluid.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In c-myc-transformed cells in particular, glutamine deprivation leads to the collapse of the TCA cycle and triggers cell death, which can be rescued by the addition of oxaloacetate or a membrane-permeable form of α-ketoglutarate (Wise et al., 2008; Yuneva et al., 2007).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Polyamine levels increase in proliferating cells; moreover, polyamines have been shown to inhibit apoptosis and promote tumor growth and invasion (Casero and Marton, 2007; Gerner and Meyskens, 2004).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
What the sources say
- Not checked yetcites Casero and Marton, 2007
- Not checked yetcites Gerner and Meyskens, 2004
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“One possibility is that the inactivation of ASL and ASS1 allows cancer cells to accumulate ornithine, which is then utilized in the production of polyamines, a class of nitrogen-containing polycationic aliphatic carbon molecules.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“For instance, sirtuins, a class of deacetylases that catalyze the removal of acetyl marks from histone and non-histone proteins, utilize NAD+ as a cofactor, while FAD serves as a cofactor for a lysine-specific demethylase LSD1 (Imai et al., 2000; Shi et al., 2004).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Reciprocally, proline oxidase (POX), which mediates proline degradation, is negatively controlled by c-myc via miR-23b, and is a p53 target as well (Donald et al., 2001; Liu et al., 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
What the sources say
- Not checked yetcites Donald et al., 2001
- Not checked yetcites Liu et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Among α-ketoglutarate-dependent dioxygenases are a TET family of DNA demethylases, Jumonji C family of histone demethylases, mRNA demethylases FTO and ALKBH5, and a family of prolyl hydroxylase (PHD) enzymes, which, among other processes, regulate HIF1α levels in response to oxygen availability and oxidative stress.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Argininosuccinate, in turn, is produced by the enzyme argininosuccinate synthase (ASS1) from citrulline and aspartate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“SAM is a product of the one-carbon metabolic pathway and is fueled by serine catabolism as described above.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Tumors that exhibit SDH- and FH loss share a number of phenotypic features that are consistent with dioxygenase inhibition, among which is a characteristic global increase in DNA methylation (Killian et al., 2013; Letouze et al., 2013; Xiao et al., 2012), as well as elevated levels of HIF1α (Selak et al., 2005).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Proline can be produced either from glutamate or from arginine-derived ornithine via a common intermediate, pyrroline-5-carboxylate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Indeed, withdrawal and readdition of glucose, as well as activation of oncogenic signaling via introduction of an oncogenic KRAS mutant or a constitutively active form of Akt, increase total histone acetylation, which, in turn, promotes the enhanced and broader gene expression (Lee et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
- Not checked yetcites Lee et al., 2014 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The de novo biosynthesis of arginine is an integral part of the urea cycle, where it is derived from argininosuccinate in a cleavage reaction catalyzed by argininosuccinate lyase (ASL).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The deposition of acetyl marks on histones is associated with the increased accessibility of the genomic DNA for the assembly of transcriptional complexes, and has a rapid turnover rate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“As discussed earlier, tumors are often faced with nutrient- and oxygen-poor surroundings and develop various nutrient-scavenging strategies to bypass these limitations.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Furthermore, hypoxia impedes the ability of cells to carry out oxidative phosphorylation and other reactions that require oxygen and disrupts the redox balance, affecting cellular signaling and transcriptional programs.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“a gasotransmitter with complex and not yet fully defined functions in cellular physiology, among which are protection from oxidative stress, increased mitochondrial respiration, protection from apoptosis and facilitation of angiogenesis (Wu et al., 2015).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
What the sources say
- Not checked yetcites Wu et al., 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Oncogene-driven metabolic reprogramming allows cancer cells to maintain deregulated proliferation, withstand metabolic challenges that are associated with oxygen and nutrient limitations, maintain a dedifferentiated state through alterations in global patterns of gene expression, and corrupt the surrounding microenvironment into actively assisting tumor growth and dissemination.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Increased extracellular acidification stimulates the proteolytic activity of matrix metalloproteinases (MMPs) and cathepsins, promoting the degradation of the extracellular matrix components and enhancing tumor invasion (Martinez-Zaguilan et al., 1996; Rothberg et al., 2013).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Martinez-Zaguilan et al., 1996
- Not checked yetcites Rothberg et al., 2013
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Thus, cancer cells upregulate the uptake of cysteine via the transcriptional upregulation of the xCT transporter, as well as secondary to the increased rate of glutamine utilization by cells (Lo et al., 2008).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
What the sources say
- Not checked yetcites Lo et al., 2008
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Thus, lactate promotes the stabilization of HIF1α and activates NF-κB and PI-3 kinase signaling in endothelial cells, as well as induces secretion of a pro-angiogenic factor VEGF from tumor-associated stromal cells (Constant et al., 2000; Schmid et al., 2007; Sonveaux et al., 2012; Vegran et al., 2011).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Constant et al., 2000 source
- Not checked yetcites Schmid et al., 2007
- Not checked yetcites Sonveaux et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“How cancer cells reprogram their microenvironment to assist tumor growth and dissemination is an area of intense investigation, but it is clear that such reprogramming encompasses multiple strategies, among which are secreted growth factors and alterations to the extracellular matrix and cell-cell interactions.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, a specific increase in the L enantiomer of 2-HG, which was shown to exert similar, but not identical, inhibitory effects on α-ketoglutarate-dependent dioxygenases was found in clear cell renal cell carcinoma, where it correlates with increased methylcytosine levels (Shim et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
- Not checked yetcites Shim et al., 2014 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Increased choline uptake is observed in breast and prostate cancer; in fact, radioactive 18F- and 11C-choline is used in the clinic for PET-based tumor imaging (Krause et al., 2013; Kwee et al., 2007).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
What the sources say
- Not checked yetcites Krause et al., 2013
- Not checked yetcites Kwee et al., 2007
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In various cellular settings, ectopic expression of a mutant IDH allele or treatment with exogenous D-2-HG is sufficient to induce DNA and histone hypermethylation and block cellular differentiation (Losman et al., 2013; Lu et al., 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
- Not checked yetcites Losman et al., 2013 source
- Not checked yetcites Lu et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Increased levels of lactate also stimulate hyaluronic acid production by fibroblasts, which may contribute to tumor invasiveness (Stern et al., 2002).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Stern et al., 2002
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Specifically, numerous solid tumor types overexpress tryptophan-degrading dioxygenases indoleamine-2, 3-dioxygenase (IDO1) and tryptophan-2, 3-dioxygenase (TDO2), which catalyze the conversion of an essential amino acid, tryptophan, into its derivative, kynurenine (Munn and Mellor, 2007).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Munn and Mellor, 2007
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Increased lactate levels promote the emergence of an immune-permissive microenvironment by attenuating dendritic and T cell activation and monocyte migration (Fischer et al., 2007; Goetze et al., 2011; Gottfried et al., 2006).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In addition, lactate stimulates the polarization of resident macrophages to a so-called M2 state, which plays a role in immunosuppression and wound healing (Carmona-Fontaine et al., 2013; Colegio et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Carmona-Fontaine et al., 2013
- Not checked yetcites Colegio et al., 2014 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Finally, kynurenine potentiates autocrine signaling through AhR on cancer cells themselves, promoting the degradation of the extracellular matrix and invasion (Opitz et al., 2011).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Opitz et al., 2011
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“While most of the studies to this point have been focused on alterations in the metabolism of glucose and glutamine, cancer cells utilize a great variety of other nutrients, among which are sulfur–containing amino acids cysteine and methionine, essential fatty acids, choline, trace metals, and vitamins.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“IDH mutations in AML are mutually exclusive with inactivating mutations in TET2 methylcytosine hydroxylases, further implicating mutant IDH as a bona fide driver of epigenetic remodeling (Figueroa et al., 2010).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
- Not checked yetcites Figueroa et al., 2010 source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a manner that is dependent on AhR, kynurenine promotes regulatory T-cell phenotype, further contributing to the suppression of antitumor immune responses (Fallarino et al., 2006).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Fallarino et al., 2006
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Micronutrients are utilized as cofactors for various enzymes and play complex and not yet fully defined roles in regulating cellular metabolic circuits, as well as signal transduction.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, copper was recently shown to be required for BRAFV600E-driven ERK activation in melanoma cells, and the effect of copper depletion could be rescued by the constitutive activation of ERK (Brady et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
What the sources say
- Not checked yetcites Brady et al., 2014
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As many cancers are characterized by increased methylation of CpG islands, alterations in ascorbic acid import may thus affect their epigenetic state as well.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“For instance, ascorbic acid acts as a cofactor for the α-ketoglutarate-dependent dioxygenases.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
Most tumors display several of the six metabolic hallmarks, while few display all six.
“While few tumors display all six hallmarks, most display several.”
The paper relies on this without support.
Findings from animal models about dietary methyl donors and epigenetic marks apply to human tumorigenesis.
“Furthermore, diets deficient in choline and betaine were shown to directly affect histone and DNA methylation in a number animal models (Du et al., 2009; Mehedint et al., 2010; Niculescu et al., 2006), suggesting that alterations in exogenous methyl donor availability may have strong effects on cellular epigenetic state and thus contribute to tumorigenesis.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even TCA cycle intermediates are not solely used to produce NADH for mitochondrial respiration, but intermediates can also be used to form nonessential amino acids and fatty acids, which facilitate protein synthesis, membrane construction and cholesterol synthesis (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
In the citing paper
“The PPP is chiefly used for NADPH and ribose synthesis to produce nucleotides (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
In the citing paper
“However, not all tumors are glutamine dependent because some tumors and embryonic stem cells are capable of proliferation without an exogenous supply of glutamine, because they can synthesize it (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,346
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Self-citationHistone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Cited by
Sorted by citations
Items 401–500 of 1,029
Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
Peng, X., He, Y., Huang, J. X., Tao, Y., & Liu, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613492 · Cited by 146
“Tumor cells can absorb them into vesicles by macropinocytosis and restore them to free amino acids by lysosomes (15).”
BackgroundPerspective of mesenchymal transformation in glioblastoma
Kim, Y., Varn, F. S., Park, S., Yoon, B. W., Park, H. R., Lee, C., Verhaak, R. G. W., & Paek, S. H. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01151-4 · Cited by 152
Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies
Zhang, Y., Li, Q., Huang, Z., Li, B., Nice, E. C., Huang, C., Wei, L., & Zou, B. (2022) · Cancers · doi:10.3390/cancers14194568 · Cited by 144
“In the 1920s, Otto Warburg first observed that cancer cells tend to metabolize glucose to lactate even in the presence of sufficient oxygen, known as the Warburg effect or aerobic glycolysis (Figure 1B) [2].”
BackgroundInfluentialKRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
Pupo, E., Avanzato, D., Middonti, E., Bussolino, F., & Lanzetti, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00848 · Cited by 151
“Even if autophagy does not increment the biomass, as it re-utilizes pre-existing molecules to generate new ones, it supports cell survival under stress condition allowing tumor persistence (36).”
BackgroundBeloueche‐Babari, M., Galobart, T. C., Delgado‐Goñi, T., Wantuch, S., Parkes, H. G., Tandy, D., Harker, J. A., & Leach, M. O. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0717-x · Cited by 148
Ding, X., Liu, M., Cheng, Q., Guo, W., Niu, M., Huang, Q., Zeng, X., & Zhang, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121369 · Cited by 146
Navarro, C., Ortega, Á., Santeliz, R., Garrido, B., Chacín, M., Galbán, N., Vera, I., Sanctis, J. B. D., & Bermúdez, V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061303 · Cited by 152
“An incremented flow of glucose provides intermediaries for different cellular pathways, among which the PPP pathway stands out, since it is the most studied, where G6PD and 6-phosphogluconate dehydrogenase participates in redox homeostasis through the generation of GSH [23] and the synthesis of glycerol-3-phosphate fo…”
BackgroundAcidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling
Nadtochiy, S. M., Schafer, X., Fu, D., Nehrke, K., Munger, J., & Brookes, P. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738799 · Cited by 143
“A prominent feature of the cancer metabolic phenotype (reviewed in (2)) is an elevated level of the small metabolic acid 2hydroxyglutarate (2-HG), derived from the TCA cycle intermediate α-ketoglutarate (α-KG) (3).”
BackgroundIdentifying strategies to target the metabolic flexibility of tumours
Méndez‐Lucas, A., Lin, W., Driscoll, P. C., Legrave, N. M., Novellasdemunt, L., Xie, C., Charles, M. D., Wilson, Z., Jones, N. P., Rayport, S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0195-8 · Cited by 148
Zacksenhaus, E., Shrestha, M., Liu, J. C., Vorobieva, I., Chung, P. E. D., Ju, Y., Nir, U., & Jiang, Z. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.002 · Cited by 143
Mitochondrial Involvement in Cisplatin Resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143384 · Cited by 145
“Today, this “Warburg effect” is currently referred to as “metabolic reprogramming” and is a recognized hallmark of cancer [31,32] even if the spotlight of metabolic transformation research is today focused on the anabolic processes.”
BackgroundMechano-induced cell metabolism promotes microtubule glutamylation to force metastasis
Torrino, S., Grasset, E. M., Audebert, S., Belhadj, I., Lacoux, C., Haynes, M., Pisano, S., Abélanet, S., Brau, F., Chan, S. Y., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.009 · Cited by 145
Schöpf, B., Weißensteiner, H., Schäfer, G., Fazzini, F., Charoentong, P., Naschberger, A., Rupp, B., Fendt, L., Bukur, V., Giese, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15237-5 · Cited by 148
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms
Gholami, M. D., Kardar, G. A., Saeedi, Y., Heidari, S., Garssen, J., & Falak, R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.002 · Cited by 143
“This phenomenon, called the “Warburg effect,” is a hallmark for cancer cell metabolism [141].”
Jovičić, E. J., Kump, A., Malavašič, P., Eichmann, T. O., Zimmermann, R., & Petan, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.12.006 · Cited by 139
Precision oncology in the age of integrative genomics
Kumar‐Sinha, C., & Chinnaiyan, A. M. (2018) · Nature Biotechnology · doi:10.1038/nbt.4017 · Cited by 138
ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis
Lu, Y., Ju, H., Liu, Z., Chen, D.-L., Wang, Y., Zhao, Q., Wu, Q.-N., Zeng, Z.-L., Qiu, H.-B., Hu, P.-S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3155 · Cited by 143
“Cancer cells often require much more NADPH supplementation for redox hemostasis, lipid oxidation, and biomolecular synthesis than their normal counterparts (19, 34, 35).”
BackgroundNon-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis
Li, M., Chiang, Y., Lyssiotis, C. A., Teater, M. R., Hong, J. Y., Shen, H., Wang, L., Hu, J., Jing, H., Chen, Z., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.002 · Cited by 143
“Cancer cells undergo metabolic reprogramming to meet their energetic and biosynthetic demands (Hanahan and Weinberg, 2011; Pavlova and Thompson, 2016).”
BackgroundThe Role of Nicotinamide in Cancer Chemoprevention and Therapy
Nikas, I. P., Paschou, S. Α., & Ryu, H. S. (2020) · Biomolecules · doi:10.3390/biom10030477 · Cited by 144
“SIRT1 inhibition by NAM could suppress metabolism, a deregulation of which is potentially oncogenic [7,9], while suppression of PARP1 could result in accumulated genetic damage in the long term [39,46].”
BackgroundGarg, M., Shanmugam, M. K., Bhardwaj, V., Goel, A., Gupta, R., Sharma, A., Baligar, P., Kumar, A. P., Goh, B. C., Wang, L., et al. (2020) · Medicinal Research Reviews · doi:10.1002/med.21761 · Cited by 143
Zhang, Y., Lin, C., Liu, Z., Sun, Y., Chen, M., Guo, Y., Liu, W., Zhang, C., Chen, W., Sun, J., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.10.012 · Cited by 149
Audet‐Walsh, É., Dufour, C. R., Yee, T., Zouanat, F. Z., Yan, M., Kalloghlian, G., Vernier, M., Caron, M., Bourque, G., Scarlata, E., et al. (2017) · Genes & Development · doi:10.1101/gad.299958.117 · Cited by 142
“Reprogrammed metabolism has been recognized as a hallmark of cancer (Hanahan and Weinberg 2011; Pavlova and Thompson 2016), including in PCa.”
Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer
Eibl, G., Cruz‐Monserrate, Z., Korc, M., Petrov, M. S., Goodarzi, M. O., Fisher, W. E., Habtezion, A., Lugea, A., Pandol, S. J., Hart, P. A., et al. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.07.005 · Cited by 148
Ma, X., Wang, L., Huang, D., Li, Y., Yang, D., Li, T., Li, F., Sun, L., Wei, H., He, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01647-5 · Cited by 140
SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis
Greene, K. S., Lukey, M. J., Wang, X., Blank, B. S., Druso, J. E., Lin, M.-C. J., Stalnecker, C. A., Zhang, C., Abril, Y. L. N., Erickson, J. W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911954116 · Cited by 138
“Transformed cells often exhibit high rates of glucose consumption coupled to lactate secretion regardless of O2 availability (the Warburg effect), as well as increased use of glutamine as a carbon and nitrogen source (1).”
BackgroundWei, J., Huang, K., Hu, M., Chen, Z., Bai, Y., Lin, S., & Du, H. (2020) · Cancers · doi:10.3390/cancers12071788 · Cited by 143
Yousefi, H., Vatanmakanian, M., Mahdiannasser, M., Mashouri, L., Alahari, N. V., Monjezi, M. R., Ilbeigi, S., & Alahari, S. K. (2021) · Oncogene · doi:10.1038/s41388-020-01588-2 · Cited by 146
Zhang, C., Liu, J., Huang, G., Zhao, Y., Yue, X., Wu, H., Li, J., Zhu, J., Shen, Z., Haffty, B. G., et al. (2016) · Genes & Development · doi:10.1101/gad.283283.116 · Cited by 140
“Increased glycolysis is the most well-studied metabolic change in cancer, which provides ATP as well as precursors and reducing equivalents for the biosynthesis of macromolecules, such as nucleotides, proteins, and lipids (DeNicola and Cantley 2015; Pavlova and Thompson 2016).”
BackgroundNitric Oxide: The Forgotten Child of Tumor Metabolism
Rizi, B. S., Achreja, A., & Nagrath, D. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.07.005 · Cited by 140
Ding, Z., Ericksen, R. E., Escande‐Beillard, N., Lee, Q. Y., Loh, A., Denil, S. L. I. J., Steckel, M., Haegebarth, A., Ho, T. S. W., Chow, P. K. H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.026 · Cited by 138
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Ata, R., & Antonescu, C. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010189 · Cited by 139
“, nucleotides, phospholipids, certain amino acids) and thus on the biosynthetic pathways that are responsible for uptake or production of these intermediates [67,68].”
BackgroundThe Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in Cancer
Fitzgerald, G., Soro-Arnáiz, I., & Bock, K. D. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00100 · Cited by 137
Using Seahorse Machine to Measure OCR and ECAR in Cancer Cells
Zhang, J., & Zhang, Q. H. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9027-6_18 · Cited by 140
Petan, T. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_51 · Cited by 145
Cancer metabolism and carcinogenesis
Yang, J., Shay, C., Saba, N. F., & Teng, Y. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00482-x · Cited by 155
Lee, H., Li, C., Ruan, D., He, J., Montal, E. D., Lorenz, S., Girnun, G. D., & Chan, C. (2019) · Nature Communications · doi:10.1038/s41467-019-10374-y · Cited by 142
Cheng, C., Geng, F., Li, Z., Zhong, Y., Wang, H., Cheng, X., Zhao, Y., Mo, X. M., Horbinski, C., Duan, W., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00568-y · Cited by 140
Tumour microenvironment factors shaping the cancer metabolism landscape
Anastasiou, D. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.412 · Cited by 138
“…are, by and large, similar to the ones in healthy tissues, changes in the expression levels of metabolic enzymes, expression of alternative enzyme isoforms or mutations in genes encoding metabolic enzymes have all been implicated in altering the metabolism of tumours (Pavlova and Thompson, 2016).”
BackgroundCompetitive glucose metabolism as a target to boost bladder cancer immunotherapy
Afonso, J., Santos, L. L., Longatto‐Filho, A., & Baltazar, F. (2020) · Nature Reviews Urology · doi:10.1038/s41585-019-0263-6 · Cited by 138
Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria
Nowinski, S. M., Solmonson, A., Rusin, S. F., Maschek, J. A., Bensard, C., Fogarty, S., Jeong, M.-Y., Lettlová, S., Berg, J. A., Morgan, J. T., et al. (2020) · eLife · doi:10.7554/elife.58041 · Cited by 141
Tang, M., Dong, X., Xiao, L., Tan, Z., Luo, X., Yang, L., Li, W., Shi, F., Li, Y., Zhao, L., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04730-y · Cited by 138
“The ready availability of a pool of nucleotides facilitates appropriate DNA repair and replication [16].”
BackgroundLiu, Y., Zhao, Y., Song, H., Li, Y., Liu, Z., Ye, Z., Zhao, J., Wu, Y. C., Tang, J., & Yao, M. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217076 · Cited by 146
Fructose 2,6-Bisphosphate in Cancer Cell Metabolism
Bartrons, R., Simon‐Molas, H., Rodríguez‐García, A., Castaño, E., Navarro‐Sabaté, À., Manzano, À., & Martinez‐Outschoorn, U. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00331 · Cited by 136
“Pharmacological inhibition of glycolysis has emerged as a novel strategy since high glycolytic activity is considered a metabolic hallmark of cancer (6, 21, 31, 34).”
BackgroundMitochondrial Calcium Regulation of Redox Signaling in Cancer
Delierneux, C., Kouba, S., Shanmughapriya, S., Potier‐Cartereau, M., Trebak, M., & Hempel, N. (2020) · Cells · doi:10.3390/cells9020432 · Cited by 138
“While large surges of ROS contribute to tumorigenesis through DNA damage, sub-lethal levels of ROS are capable of activating signaling pathways that regulate cancer cell growth and progression [53,84,85].”
BackgroundKolb, D., Kolishetti, N., Surnar, B., Sarkar, S., Guin, S., Shah, A. S., & Dhar, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b10037 · Cited by 137
Kindlin-2 links mechano-environment to proline synthesis and tumor growth
Guo, L., Cui, C., Zhang, K., Wang, J., Wang, Y., Lu, Y., Chen, K., Yuan, J., Xiao, G., Tang, B. H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08772-3 · Cited by 130
Kong, C., Li, Y., Liu, Z., Ye, J., Wang, Z., Zhang, L., Kong, W., Liu, H., Liu, C., Pang, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b08246 · Cited by 127
Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-β
Yin, X., Choudhury, M., Kang, J. H., Schaefbauer, K. J., Jung, M.-Y., Andrianifahanana, M., Hernandez, D. M., & Leof, E. B. (2019) · Science Signaling · doi:10.1126/scisignal.aax4067 · Cited by 133
“A role for altered metabolism has been extensively investigated in neoplastic diseases (29, 30), but analogous reports in fibroproliferative disorders are relatively limited (31–34).”
BackgroundMetabolic Fitness and Plasticity in Cancer Progression
McGuirk, S., Audet-Delage, Y., & St‐Pierre, J. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.11.009 · Cited by 133
Kumar, H., Gupta, N., Jain, R., Madhunapantula, S. V., Babu, C. S., Kesharwani, S. S., Dey, S., & Jain, V. K. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.02.005 · Cited by 143
“Recently, several mitochondrial targeted therapies were developed for the treatment of TNBC. Cancerous cells are dependent on exogenous amino acid supplements to produce energy [203].”
BackgroundStimulated Raman scattering flow cytometry for label-free single-particle analysis
Zhang, C., Huang, K., Rajwa, B. P., Li, J., Yang, S., Lin, H., Liao, C., Eakins, G. S., Kuang, S., Patsekin, V., et al. (2017) · Optica · doi:10.1364/optica.4.000103 · Cited by 132
Tumor Microenvironment: Lactic Acid Promotes Tumor Development
Gao, Y., Zhou, H., Liu, G., Wu, J., Yuan, Y., & Shang, A. (2022) · Journal of Immunology Research · doi:10.1155/2022/3119375 · Cited by 143
“CAF can deliver lactate to oxidative tumor cells via TCA while also maintaining tumor growth and metastasis via mitochondrial oxidative phosphorylation, a phenomenon known as the anti-Warburg e ff ect [24, 25].”
Precancer Atlas to Drive Precision Prevention Trials
Spira, A. E., Yurgelun, M. B. B., Alexandrov, L. B., Rao, A., Bejar, R., Polyák, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 134
“Mutations in nuclear DNA genes influencing transformation involve some of the same targets/mechanisms affected by mtDNA – TETs, succinate, fumarate, NRF2, and a-ketoglutarate dioxygenases (83, 96, 97, 104).”
BackgroundInfluentialOchocki, J. D., Khare, S., Hess, M., Ackerman, D., Qiu, B., Daisak, J. I., Worth, A. J., Lin, N., Lee, P., Xie, H. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.009 · Cited by 128
“Consequently, pharmacological inhibition of specific metabolic pathways may preferentially limit tumor cell growth and proliferation, and multiple metabolism-based therapies are currently in development (Pavlova and Thompson, 2016; Vander Heiden and DeBerardinis, 2017; Yen et al., 2017).”
The therapeutic implications of immunosuppressive tumor aerobic glycolysis
Reinfeld, B. I., Rathmell, W. K., Kim, T. K., & Rathmell, J. C. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00727-3 · Cited by 135
Lipid droplets: a cellular organelle vital in cancer cells
Jin, Y., Tan, Y., Wu, J., & Ren, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01493-z · Cited by 150
FoxO transcription factors in cancer metabolism
Yadav, R. K., Chauhan, A. S., Zhuang, L., & Gan, B. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.004 · Cited by 138
Metabolic reprogramming and its clinical implication for liver cancer
Yang, F., Hilakivi-Clarke, L. A., Shaha, A., Wang, Y., Wang, X., Deng, Y., Lai, J., & Kang, N. (2023) · Hepatology · doi:10.1097/hep.0000000000000005 · Cited by 140
“[4,5] In a nonmalignant cell, ATPs are mainly generated by the breakdown of energy inputs, such as glucose, fatty acids (FAs), and amino acids, through multiple biochemical processes like glycolysis, the tricarboxylic acid (TCA) cycle, oxidative phosphorylation (OXPHOS), beta-oxidation, amino acid…”
BackgroundMetabolic requirement for GOT2 in pancreatic cancer depends on environmental context
Kerk, S. A., Lin, L., Myers, A. L., Sutton, D. J., Andren, A., Sajjakulnukit, P., Zhang, L., Zhang, Y., Jiménez, J. A., Nelson, B. S., et al. (2022) · eLife · doi:10.7554/elife.73245 · Cited by 108
Morrot, A., da Fonseca, L. M., Salustiano, E. J., Gentile, L. B., Conde, L., Filardy, A. A., Franklim, T. N., da Costa, K. M., Freire-de-Lima, C. G., & Freire‐de‐Lima, L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00081 · Cited by 128
“Reprogramming of cellular metabolism has been observed in several types of cancer and is considered a hallmark of this disease (3, 20).”
BackgroundCheng, A., Zhang, P., Wang, B., Yang, D., Duan, X., Jiang, Y., Tian, X., Jiang, Y. P., Shi, J., Ding, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13485-8 · Cited by 124
Measuring Tumor Glycolytic Flux in Vivo by Using Fast Deuterium MRI
Kreis, F., Wright, A. J., Hesse, F., Fala, M., Hu, D., & Brindle, K. M. (2019) · Radiology · doi:10.1148/radiol.2019191242 · Cited by 127
Reprogramming of serine, glycine and one-carbon metabolism in cancer
Li, A. M., & Ye, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165841 · Cited by 127
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
Ma, X., Yang, S., Zhang, T., Wang, S., Yang, Q., Xiao, Y., Shi, X., Xue, P., Kang, Y., Liu, G., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.016 · Cited by 125
Zhang, H., Yu, X., Ye, J., Li, H., Hu, J., Tan, Y., Fang, Y., Akbay, E. A., Yu, F., Weng, C., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.09.003 · Cited by 137
Vitamin D and the Liver—Correlation or Cause?
Keane, J. T., Elangovan, H., Stokes, R., & Gunton, J. E. (2018) · Nutrients · doi:10.3390/nu10040496 · Cited by 126
“Given the role of the fibrogenic phenotype as a tumorigenic niche which dampens the fibrotic response, in particular by modulating HSC activation [78], or modulating cancer immunology [87] through the use of VDR ligands, these models are potential future therapeutic strategies for HCC.”
BackgroundWei, F., Wang, D., Wei, J., Tang, N., Tang, L. M., Xiong, F., Guo, C. J., Zhou, M., Li, X., Li, G., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03581-0 · Cited by 128
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients
Zhao, F., An, R., Wang, L., Shan, J., & Wang, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.725284 · Cited by 129
“Lipids, especially phospholipids, participate in cellular trans-membrane transport, energy metabolism, signal transduction and cancer development (Pendaries et al., 2003; Ogretmen and Hannun, 2004; Gorke et al., 2010; Lee et al., 2012; Santos and Schulze, 2012).”
BackgroundKumar, P., Gupta, S., & Das, B. C. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101827 · Cited by 136
Zhang, J., Yao, M., Xia, S., Zeng, F., & Liu, Q. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00682-7 · Cited by 150
Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
Schwab, A., Siddiqui, A., Vazakidou, M. E., Napoli, F., Böttcher, M., Menchicchi, B., Raza, U., Saatci, Ö., Krebs, A. M., Ferrazzi, F., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2834 · Cited by 128
“The study of metabolic processes represents an emerging field in cancer biology (35) with a great translational potential (14,36-38).”
BackgroundDu, Q., Tan, Z., Shi, F., Tang, M., Xie, L., Zhao, L., Li, Y., Hu, J., Zhou, M., Bode, A. M., et al. (2019) · Cancer Science · doi:10.1111/cas.14011 · Cited by 124
Liu, N., Zhang, J., Yin, M., Liu, H., Zhang, X., Li, J., Yan, B., Guo, Y., Zhou, J., Tao, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.013 · Cited by 130
Chen, X., Hao, Y., Liu, Y., Zhong, S., You, Y., Ao, K., Chong, T., Luo, X., Yin, M., Ye, M., et al. (2023) · Advanced Science · doi:10.1002/advs.202302705 · Cited by 128
Woolf, E. C., Syed, N., & Scheck, A. C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00122 · Cited by 126
“…and Thompson, 2012; Semenza, 2013; Gaude and Frezza, 2014; Masson and Ratcliffe, 2014; Boroughs and DeBerardinis, 2015; Casey et al., 2015; Robey et al., 2015; Asati et al., 2016; Barron et al., 2016; Bost et al., 2016; Molon et al., 2016; Pavlova and Thompson, 2016; PérezEscuredo et al., 2016).”
BackgroundCanagliflozin extends life span in genetically heterogeneous male but not female mice
Miller, R. A., Harrison, D. E., Allison, D. B., Bogue, M. A., Debarba, L. K., Diaz, V., Fernández, E., Gałecki, A. T., Garvey, W. T., Jayarathne, H. S. M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140019 · Cited by 127
Pyruvate carboxylase and cancer progression
Kiesel, V. A., Sheeley, M. P., Coleman, M. F., Kulkoyluoglu‐Cotul, E., Donkin, S. S., Hursting, S. D., Wendt, M. K., & Teegarden, D. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00256-7 · Cited by 131
“such as fatty acid synthesis limits NADH and ATP production from oxidative metabolism of glucose, both of which are negative regulators of glycolysis [14].”
BackgroundConnections Between Metabolism and Epigenetics in Programming Cellular Differentiation
Chisolm, D. A., & Weinmann, A. S. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053127 · Cited by 133
Cancer Metabolism Drives a Stromal Regenerative Response
Schwörer, S., Vardhana, S. A., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.015 · Cited by 125
“We have previously proposed the metabolic interaction of cancer cells with the tumor microenvironment as a hallmark of cancer metabolism (Pavlova and Thompson, 2016).”
BackgroundSelf-citationLi, L.-Y., Yang, Q., Jiang, Y.-Y., Yang, W., Jiang, Y. Y., Li, X., Hazawa, M., Zhou, B. O., Huang, G.-W., Xu, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24656-x · Cited by 125
Calculation of ATP production rates using the Seahorse XF Analyzer
Desousa, B. R., Kim, K. K. O., Jones, A. E., Ball, A. B., Hsieh, W. Y., Swain, P. M., Morrow, D., Brownstein, A. J., Ferrick, D. A., Shirihai, O. S., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256380 · Cited by 135
“Biological processes such as stem cell pluripotency (Gu et al , 2016), oncogenesis (DeBerardinis & Chandel, 2020), growth factor signaling (Pavlova & Thompson, 2016), and immune cell activation (van den Bossche et al , 2017) are therefore frequently associated with a preferential shift towards…”
BackgroundThe significant role of amino acid metabolic reprogramming in cancer
Liu, X., Ren, B., Ren, J., Gu, M., You, L., & Zhao, Y.-P. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01760-1 · Cited by 147
“Metabolic reprogramming in non-cancer cells, such as stromal fibroblasts and bone marrow adipocytes, as well as metabolic interactions among various cell types within the tumor microenvironment, represent emerging characteristics of cancer metabolism [1].”
BackgroundNeuro-immune crosstalk in cancer: mechanisms and therapeutic implications
Pu, T., Sun, J., Ren, G., & Li, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02241-8 · Cited by 155
Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
Miranda‐Gonçalves, V., Lameirinhas, A., Henrique, R., & Jerónimo, C. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00427 · Cited by 125
Mid-infrared metabolic imaging with vibrational probes
Shi, L., Liu, X., Shi, L., Stinson, H. T., Rowlette, J. A., Kahl, L. J., Evans, C. R., Zheng, C., Dietrich, L. E. P., & Min, W. (2020) · Nature Methods · doi:10.1038/s41592-020-0883-z · Cited by 126
Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics
Wei, Y., Jasbi, P., Shi, X., Turner, C., Hrovat, J., Liu, L., Rabena, Y., Porter, P. L., & Gu, H. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00019 · Cited by 128
Intracellular and microenvironmental regulation of mitochondrial membrane potential in cancer cells
Begum, H. M., & Shen, K. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1595 · Cited by 126
Fatty acid metabolism of immune cells: a new target of tumour immunotherapy
Zhang, S., Lv, K., Liu, Z., Zhao, R., & Li, F. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01807-9 · Cited by 141
Phenformin as an Anticancer Agent: Challenges and Prospects
Rubiño, M. E. G., Carrillo, E., Ruiz-Alcalá, G., Domínguez‐Martín, A., Marchal, J. A., & Boulaiz, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133316 · Cited by 125
“Essentially, the tumor metabolism is characterized by the following: (1) Low respiratory rate: conditions of hypoxia that lead to low local availability of oxygen and an anaerobic metabolism [27].”
BackgroundEpigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Li, T., Mao, C., Wang, X., Shi, Y., & Tao, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01733-5 · Cited by 125
“Growing evidence have shown that tumors prefer glycolysis, even in aerobic conditions [14].”
BackgroundCastañeda-Cifuentes, A. M., Meléndez, C. M., Uribe, D., & Pedroza-Díaz, J. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09519 · Cited by 133
“Fortunately, in the last decades remarkable progress into the mechanisms of cancer pathogenesis has been achieved, which has allowed to determine the “hallmark” capabilities of cancer cells during tumor onset and progression and also, the exploration of new cancer treatment strategies [1, 2, 3].”
BackgroundOncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
Zhu, T., Hong, L., & Ling, Z. (2023) · Biomarker Research · doi:10.1186/s40364-023-00499-0 · Cited by 121
“These processes support cancer progression directly or through enhancing crosstalks with the surrounding tumor microenvironment (TME), which includes immune cells, fibroblasts, endotheliocytes, and extracellular matrix [77].”
Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca 2+ –NFAT signalingPreprint
Lee, J. V., Berry, C. T., Kim, K., Sen, P., Kim, T., Carrer, A., Trefely, S., Zhao, S., Fernandez, S., Barney, L. E., et al. (2018) · Genes & Development · doi:10.1101/gad.311027.117 · Cited by 121
“Ifng expression, for example, is regulated in part by glycolysis-dependent histone acetylation (Peng et al. 2016), and ACLY has been shown to regulate cytokine-induced gene expression (Osinalde et al. 2016).”
BackgroundThe metabolic modulator PGC-1α in cancer.
Bost, F., & Kaminski, L. (2019) · Europe PMC (PubMed Central) · Cited by 119
Zhao, S., Lu, C., Shi, Y., Li, J., Yun, Q., & Yang, H. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03336-6 · Cited by 118
Vantaku, V., Dong, J., Ambati, C. R., Perera, D. N., Donepudi, S. R., Amara, C. S., Putluri, V., Ravi, S. S., Robertson, M. J., Piyarathna, D. W. B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1515 · Cited by 116
“Tumor progression relies on the reprogramming of cellular metabolism (7).”
BackgroundLiu, X., Liu, Y., Liu, Z., Lin, C., Meng, F., Xu, L., Zhang, X., Zhang, C., Zhang, P., Gong, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01412-9 · Cited by 121
“Tumour cells reprogram their metabolic pathways to meet the material and energy requirements of rapid proliferation [2].”
BackgroundACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis
Yang, Z., Zou, S., Zhang, Y., Zhang, J., Zhang, P., Xiao, L., Xie, Y., Meng, M., Feng, J., Kang, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39901-8 · Cited by 124
Mutational landscape of cancer-driver genes across human cancers
Sinkala, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-39608-2 · Cited by 154
“These exceptions reinforce the notion that multiple routes to oncogenesis may be independent of cancer gene mutations and involve alterations in other regulatory mechanisms, such as the epigenome 1,7,56 .”
Genetic alterations in Krebs cycle and its impact on cancer pathogenesis
Sajnani, K., Islam, F., Smith, R. A., Gopalan, V., & Lam, A. K.-Y. (2017) · Biochimie · doi:10.1016/j.biochi.2017.02.008 · Cited by 121
Metadata
- Authors
- Pavlova, N. N., & Thompson, C. B.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Thompson, Craig B.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 23
- Issue
- 1
- Pages
- 27-47
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4715268
- OpenAlex
- W2234115940
- Semantic Scholar
- 1e8b6414a84ad7a310eeee976435e51a609d3979
- Cited by
- 5,926
- References
- 254
- Citations by year
- 2026: 576 · 2025: 556 · 2024: 661 · 2023: 678 · 2022: 819 · 2021: 846 · 2020: 601 · 2019: 477 · 2018: 352 · 2017: 252 · 2016: 103
- FWCI
- 36.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 377 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute
- Terri Brodeur Breast Cancer Foundation
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, carcinogenesis, glucose uptake, amino acid uptake, nutrient acquisition, glycolysis, TCA cycle intermediates, NADPH production, nitrogen requirements, tumor microenvironment, tumor classification
- MeSH terms
- Animals, Antineoplastic Agents, Biological Transport, Cell Transformation, Neoplastic, Energy Metabolism, Humans, Mutation, Neoplasms, Signal Transduction, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review